checkAd
    Kiniksa Pharmaceuticals Registered (A) Aktie
    19,010
     
    USD
    +2,37 %
    +0,440 USD
    Letzter Kurs 01.06.24 Nasdaq
    19,000
     
    USD
    800 STK
    Geldkurs 31.05.24
    19,010
     
    USD
    3.100 STK
    Briefkurs 31.05.24
    ISIN: BMG5269C1010 · WKN: A2JMVJ · SYM: KNSA · Bermuda-Inseln

    Neueste Nachrichten

    Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference
    07.05.24 · globenewswire · Kiniksa Pharmaceuticals Registered (A)
    Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution
    23.04.24 · globenewswire · Kiniksa Pharmaceuticals Registered (A)
    Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024
    16.04.24 · globenewswire · Kiniksa Pharmaceuticals Registered (A)
    Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart
    02.04.24 · globenewswire · Kiniksa Pharmaceuticals Registered (A)
    Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution
    28.02.24 · globenewswire · Kiniksa Pharmaceuticals Registered (A)
    Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
    21.02.24 · globenewswire · Kiniksa Pharmaceuticals Registered (A)
    Kiniksa Pharmaceuticals Provides Corporate Update
    04.01.24 · globenewswire · Kiniksa Pharmaceuticals Registered (A)
    Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference
    02.01.24 · globenewswire · Kiniksa Pharmaceuticals Registered (A)
    Kiniksa Pharmaceuticals Reports Third Quarter 2023 Financial Results and Recent Portfolio Execution
    31.10.23 · globenewswire · Kiniksa Pharmaceuticals Registered (A)
    Kiniksa Pharmaceuticals to Report Third Quarter 2023 Financial Results on October 31, 2023
    24.10.23 · globenewswire · Kiniksa Pharmaceuticals Registered (A)
    Kiniksa Pharmaceuticals Reports Second Quarter 2023 Financial Results and Recent Portfolio Execution
    25.07.23 · globenewswire · Kiniksa Pharmaceuticals Registered (A)
    Kiniksa Pharmaceuticals to Report Second Quarter 2023 Financial Results on July 25, 2023
    18.07.23 · globenewswire · Kiniksa Pharmaceuticals Registered (A)